Fadi Issa
@fgissa
Followers
555
Following
1K
Media
10
Statuses
198
Professor of Transplantation | Editor in Chief @BMJImmunology | Executive Editor of @TransplantJrnl | Surgeon & researcher exploring immune tolerance
United Kingdom
Joined January 2009
We're excited to share our latest research, published in @NatureComms. Engineering "off the shelf" Tregs for use in transplantation. A great collaboration with our colleagues in Berlin.
0
4
8
#ISOT2025 Jaipur, Dr Fadi Issa, Executive Editor of Transplantation received ISOT Recognition Award from Hon’ble Mr. Justice Prasanna Varale, Justice, Supreme Court of India for his leadership in transplantation@balwani__manish @ttsorg @TransplantJrnl @fgissa
0
3
8
@drvivekkute @gustavoftx @ttsorg @fgissa presenting his amazing work with cellular therapies after solid organ transplant, here at ISOT in Jaipur @drvivekkute #ISOT2025
1
3
9
Exciting news 🎉 BMJ Immunology is now open for submissions! As Editor in Chief, I’m proud to launch this new home for cutting-edge immunology research. Explore and submit here 👉
bmjimmunology.bmj.com
BMJ Immunology is a new international peer reviewed journal publishing original research, review articles and opinion covering all aspects of immunology.
0
4
9
Meet the editor Fadi Issa at ISOT 2025 Jaipur! 🌟 @TransplantJrnl's @fgissa & @trig_oxford join @ttsorg for groundbreaking discussions! 💡 Shaping the future of transplantation! 🔥 #ISOT2025 #Transplantation #PublishingLeaders" @balwani__manish
0
7
13
Congratulations to @fgissa who has been appointed as our new Professor of Transplantation at the Nuffield Department of Surgical Sciences👏 Read more ➡️ https://t.co/HdUTqM9DCk
1
4
20
Kidney disease is a worldwide killer. Treat it that way
nature.com
Nature - The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of chronic kidney disease.
0
3
7
We are happy to share this news, congratulations @fgissa 👏 New Professor of Transplantation appointed
nds.ox.ac.uk
Fadi Issa has been appointed as our new Professor of Transplantation at the Nuffield Department of Surgical Sciences (NDS), following an internationally competitive appointment process. He will take...
0
3
17
Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort study - Journal of the American Academy of Dermatology https://t.co/On8O0jRDFY Improving risk prediction in melanoma patients @fgissa @GeorgeAdigbli
jaad.org
The American Joint Committee on Cancer eighth edition substaging might be suboptimal for predicting melanoma progression. Using it to select stage II patients for adjuvant immunotherapy risks...
0
1
1
The January issue of @TXPDirect is jam-packed with useful information for our diverse international transplantation readership. We welcome you to visit our Transplantation Direct website for full details in open-access. #OpenAccess #TransplantTwitter
https://t.co/0grMQgb1RD
0
3
6
"Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants." https://t.co/0jSuEzrjD3 The latest work from our lab, out now! Perfect for some holiday reading 🧑🔬
0
1
8
A big thank you to our patients, co-authors and collaborators for making this work possible @NDSurgicalSci @olivermccallion @trig_oxford
0
0
2
Why does this matter? 💡 Treg therapy offers a pathway to reduce reliance on lifelong immunosuppression in kidney transplants. 💡 Our findings highlight the potential for local immune regulation within the graft, paving the way for safer and more effective treatments.
1
0
2
Key findings: 1️⃣ Treg-treated kidney transplant patients showed excellent long-term outcomes with no rejection episodes over 7 years. 2️⃣ Distinct immune infiltrates were observed, enriched with regulatory genes like IL10, PD-L1, and TIGIT, and a significant presence of B cells.
1
0
0
🚨New! 🚨 Our new paper is now out in @MedCellPress
https://t.co/owgeByuhYs Discover how clinical Treg therapy shapes immune responses in transplants
1
5
11
Expert insights! @ElmiMuller shares latest on Once-Daily Tacrolimus at #ISOT2024 Masterclass. #TransplantMedicine @IndiaSoTx @balwani__manish @ttsorg @WIT_TTS @HakimNadey @fgissa @germjacq @ISOT24ahmedabad
0
6
11
Only 10% of global transplant demand is being met, according to the Global Observatory on Donation and Transplantation. On the cover, our Editorial explores the valuable lessons the Spanish transplantation system offers for other nations: https://t.co/UXP9jVyDt4
4
77
140
Very pleased to share our review presenting the latest literature on regulatory cell therapy for #kidney #transplantation, #glomerulonephritis & #autoimmune kidney diseases https://t.co/nvFmQ0RmBT…
@trig_oxford @mysgh @dukenus
1
1
7